Table 4 Clinical parameters, the size of CAP lesion and the concentration of inflammatory markers in the control group and patients with apoAI ≥ 150 mg/dl and apoAI ≤ 150 mg/dl and all patients with CAP, median (min- max)

Age

40(32–50)

55(32–69)*

61(37–69)*

61(32–69)

BMI (kg/m² )

23(21–25)

23(20–28)

25(21–38)

24(20–38)

sCAP (mm²)

-

33(9.4–120)

32(4–50)

32(4–120)

IL6 (pg/ml)

0.35(0.22–0.55)

0.55(0.220–3.15)

1.14(0.13–4.20)*

1.06(0.13–4.20)*

TNF-α (pg/ml)

1.09(0.42–1.55)

1.21(0.31–8.77)

3.55(0.42–1.24)*,***

3.37(0.31–8.77)*

LpPLA2(ng/ml)

57(32–93)

157(32–327)*

202(80–328)*

188(32–328)*

hsCRP mg/L

0.014(0.017–0.075)

0.155(0.010–0.789)**

0.378(0.010–1.10)**,***

0.338(0.01–1.10)**,***